Suchergebnisse - "Barricklow, Jason"

PubPharm (12)

1

Using Mitra sampling to support first-in-human pharmacokinetic evaluations for PF-07059013

enthalten in: Bioanalysis | 2023

von Lee, K. | Wan, K. | Barricklow, J. | +6

2

An orthogonal methods assessment of topical drug concentrations in skin and the impact for risk assessment in the viable epidermis

enthalten in: Regulatory toxicology and pharmacology : RTP | 2021

von Hollingshead, B. | Tomlinson, L. | Finley, J. | +16

3

Evaluation of OptiFlow™-MS/MS for bioanalysis of pharmaceutical drugs and metabolites

enthalten in: Bioanalysis | 2020

von Barricklow, J. | Tweed, J. | Holliman, C. | +1

4

Evaluation of OptiFlow™-MS/MS for bioanalysis of pharmaceutical drugs and metabolites

enthalten in: Bioanalysis | 2019

von Barricklow, J. | Tweed, J. | Holliman, C. | +1

5

Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models

enthalten in: EBioMedicine | 2018

von Esquejo, R. | Salatto, C. | Delmore, J. | +25

CommentIn: EBioMedicine. 2018 May;31:15-16. - PMID 29754882

6

Discovery and Characterization of (R)-6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in both Rat and Nonhuman Primates

enthalten in: Journal of medicinal chemistry | 2017

von Stepan, A. | Claffey, M. | Reese, M. | +37

7

2-Arachidonoylglycerol is a substrate for butyrylcholinesterase : A potential mechanism for extracellular endocannabinoid regulation

enthalten in: Archives of biochemistry and biophysics | 2013

von Barricklow, J. | Blatnik, M.

8

2-Arachidonoylglycerol is a substrate for butyrylcholinesterase: A potential mechanism for extracellular endocannabinoid regulation

enthalten in: Archives of biochemistry and biophysics | 2013

von Barricklow, J. | Blatnik, M.

9

Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analyses

enthalten in: The Journal of pharmacology and experimental therapeutics | 2012

von Lu, Y. | Riddell, D. | Hajos-Korcsok, E. | +15

10

Profile of selective ORL1 antagonist demonstrates mechanism safe to target for symptomatic treatment in Alzheimer's Disease

enthalten in: Alzheimer's & dementia | 2011

von Duplantier, A. | Iyer, R. | Pettersen, B. | +12